SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in ORKA — Oruka Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA

Back to ORKA Full portfolio

Position in ORKA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$436,639

-$592,626 QoQ

Shares Held

4,588

-78.1% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#179

of 254 holders

Holding Since

Dec 2020

21 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in ORKA Over Time

Shares Held

Position Value (USD)

Derivatives in ORKA

reported options exposure · as of Jun 30, 2026

CallValue

$15,074,928

CallShares

158,400

PutValue

$11,115,856

PutShares

116,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,997,309 across 349 Biotechnology names. ORKA ranks #169 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	1,053,896	$140,442,180
2	CYTK	Cytokinetics Inc	1,549,458	$131,998,327
3	REGN	Regeneron Pharmaceuticals, Inc.	180,219	$112,373,755
4	ALNY	Alnylam Pharmaceuticals, Inc.	294,460	$88,641,293
5	MDGL	Madrigal Pharmaceuticals, Inc.	148,610	$79,796,139
6	INSM	INSMED Inc	729,354	$77,763,723
7	VRTX	Vertex Pharmaceuticals Inc / Ma	144,174	$71,615,550
8	AGIO	Agios Pharmaceuticals, Inc.	1,375,558	$51,046,957

All Filings in ORKA

Export CSV

42 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$436,639	4,588	-78.1%	Shares	Other	2026-08-14
2026-06-30	$11,115,856	116,800	+489.9%	Put	Other	2026-08-14
2026-06-30	$15,074,928	158,400	+438.8%	Call	Other	2026-08-14
2026-03-31	$971,190	19,800	+34.7%	Put	Other	2026-05-15
2026-03-31	$1,442,070	29,400	+70.9%	Call	Other	2026-05-15
2026-03-31	$1,029,265	20,984	+142.2%	Shares	Other	2026-05-15
2025-12-31	$521,332	17,200	+33.3%	Call	Other	2026-02-17
2025-12-31	$445,557	14,700	-79.8%	Put	Other	2026-02-17
2025-12-31	$262,636	8,665	-74.5%	Shares	Other	2026-02-17
2025-09-30	$1,396,098	72,600	—	Put	Other	2025-11-14
2025-09-30	$248,067	12,900	+3.2%	Call	Other	2025-11-14
2025-06-30	$380,714	33,962	-90.3%	Shares	Other	2025-08-14
2025-03-31	$3,591,369	350,036	—	Shares	Other	2025-05-14
2024-09-30	$306,375	12,500	—	Call	Defined	2024-11-14
2024-06-30 ABIO	—	19,500	+25.0%	Call	Defined	2024-08-15
2023-12-31 ABIO	—	15,600	-45.5%	Call	Defined	2024-02-14
2023-09-30 ABIO	—	28,600	-30.2%	Call	Defined	2023-11-14
2023-06-30 ABIO	—	41,000	-19.0%	Call	Defined	2023-08-11
2023-03-31 ABIO	—	50,600	+11.0%	Call	Defined	2023-05-16
2023-03-31 ABIO	—	69,500	+51.4%	Put	Defined	2023-05-16
2022-12-31 ABIO	—	45,900	-94.6%	Put	Defined	2023-02-14
2022-12-31 ABIO	—	45,600	-46.9%	Call	Defined	2023-02-14
2022-09-30 ABIO	—	85,900	-29.1%	Call	Defined	2022-11-14
2022-09-30 ABIO	—	314,213	+37.9%	Shares	Defined	2022-11-14
2022-09-30 ABIO	—	856,300	-3.0%	Put	Defined	2022-11-14
2022-06-30 ABIO	—	121,200	+107.2%	Call	Defined	2022-08-15
2022-06-30 ABIO	—	227,917	+610.8%	Shares	Defined	2022-08-15
2022-06-30 ABIO	—	882,900	+1920.4%	Put	Defined	2022-08-15
2022-03-31 ABIO	—	43,700	-2.2%	Put	Defined	2022-05-16
2022-03-31 ABIO	—	58,500	+18.4%	Call	Defined	2022-05-16
2021-12-31 ABIO	—	44,700	-38.9%	Put	Defined	2022-04-05
2021-12-31 ABIO	—	49,400	+274.2%	Call	Defined	2022-04-05
2021-12-31 ABIO	—	32,067	-70.9%	Shares	Defined	2022-04-05
2021-09-30 ABIO	—	110,035	+8.1%	Shares	Defined	2021-11-15
2021-09-30 ABIO	—	73,100	+26.3%	Put	Defined	2021-11-15
2021-06-30 ABIO	—	57,900	+157.3%	Put	Defined	2021-08-11
2021-06-30 ABIO	—	101,747	-4.6%	Shares	Defined	2021-08-11
2021-03-31 ABIO	—	13,200	—	Call	Defined	2021-05-17
2021-03-31 ABIO	—	22,500	+80.0%	Put	Defined	2021-05-17
2021-03-31 ABIO	—	106,602	+230.6%	Shares	Defined	2021-05-17
2020-12-31 ABIO	—	32,245	—	Shares	Defined	2021-02-16
2020-12-31 ABIO	—	12,500	—	Put	Defined	2021-02-16
No filing history on record for this holder in this stock.